P507: AGREEMENT BETWEEN REAL-WORLD PHYSICIAN RESPONSE ASSESSMENT AND THE 2017 EUROPEAN LEUKEMIANET (ELN) CRITERIA IN ACUTE MYELOID LEUKEMIA (AML): A COMPARATIVE ANALYSIS

P507: AGREEMENT BETWEEN REAL-WORLD PHYSICIAN RESPONSE ASSESSMENT AND THE 2017 EUROPEAN LEUKEMIANET (ELN) CRITERIA IN ACUTE MYELOID LEUKEMIA (AML): A COMPARATIVE ANALYSIS

Bibliographic Details
Main Authors:	P. A. Patel, F. Hoff, A. J. Belli, E. Hansen, C. Anderson, A. Barcellos, L. L. Fernandes, H. Foss, M. He, M. Schulte, C.-K. Wang
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000844916.41084.6a

Similar Items

S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA
by: Marius Bill, et al.
Published: (2023-08-01)

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
by: Schuurhuis, G, et al.
Published: (2018)

Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia
by: Ga-Young Song, et al.
Published: (2024-04-01)

A three-gene expression-based risk score can refine the European LeukemiaNet AML classification
by: Stefan Wilop, et al.
Published: (2016-09-01)

AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report
by: Era L. Pogosova-Agadjanyan, et al.
Published: (2020-08-01)

Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation
by: Madlen Jentzsch, et al.
Published: (2022-12-01)

P694: RISK ASSESSMENT ACCORDING TO IPSS-M IS SUPERIOR TO AML ELN 2022 RISK CLASSIFICATION IN MDS/AML PATIENTS DEFINED BY ICC – IS AN INCLUSION INTO AML TRIALS JUSTIFIED?
by: Sandra Huber, et al.
Published: (2023-08-01)

P504: CLINICAL MUTATIONAL ANALYSIS BY NEXT-GENERATION SEQUENCING AND REAL-LIFE VALIDATION OF THE REVISED 2017 EUROPEAN LEUKEMIANET GENETIC RISK STRATIFICATION IN AML PATIENTS
by: C. Aparicio Pérez, et al.
Published: (2022-06-01)

Secondary-Type Mutations in Acute Myeloid Leukemia: Updates from ELN 2022
by: Ian M. Bouligny, et al.
Published: (2023-06-01)

The new European leukemianet recommendations for treating CML
by: Rüdiger Hehlmann
Published: (2020-10-01)

P508: THE PROGNOSTIC SIGNIFICANCE OF THE MEASURABLE RESIDUAL DISEASE STATUS WITHIN THE THREE AML ELN2022 RISK GROUPS
by: Lara Bischof, et al.
Published: (2023-08-01)

European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response
by: K. H. Begna, et al.
Published: (2022-01-01)

P437: SURVIVAL-BASED 4-GENE PROGNOSTIC INDEX IMPROVES THE ELN-RISK CLASSIFICATION IN ACUTE MYELOID LEUKEMIA
by: C. A. Ortiz Rojas, et al.
Published: (2022-06-01)

Trilobites of the Middle Ordovician Elnes Formation of the Oslo region, Norway /
by: Hansen, Thomas (Thomas F.)
Published: (c200)

Effects of Intermittent Fasting on Response to Tyrosine Kinase Inhibitors (TKIs) in Patients With Chronic Myeloid Leukemia: An Outcome of European LeukemiaNet Project
by: Mohamed A. Yassin MBBS, MSc, et al.
Published: (2021-04-01)

Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine
by: Mihee Kim, et al.
Published: (2024-12-01)

PB1867: ACUTE MYELOID LEUKEMIA WITH MUTATED NPM1 – REAL-LIFE EXPERIENCE IN THE REDEFINITION OF EUROPEAN LEUKEMIANET RISK CLASSIFICATION
by: Rita S Gomes, et al.
Published: (2023-08-01)

Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party
by: Jesse M. Tettero, et al.
Published: (2022-01-01)

European LeukemiaNet Response Predicts Disease Progression but Not Thrombosis in Polycythemia Vera
by: Douglas Tremblay, et al.
Published: (2022-06-01)

The latest edition of WHO and ELN guidance and a new risk model for Chinese acute myeloid leukemia patients
by: Xiaoning Wang, et al.
Published: (2023-06-01)

Clinicopathological Variables and Outcome in Chronic Myeloid Leukemia Associated With BCR-ABL1 Transcript Type and Body Weight: An Outcome of European LeukemiaNet Project
by: Mohammad A. J. Abdulla MD, et al.
Published: (2021-08-01)

Artículo de Presentación: Escuela Latinoamericana de Negocioss (ELN): Escuela Latinoamericana de Negocios (ELN): Una reflexión inicial
by: Oscar Javier Montiel Méndez
Published: (2021-09-01)

SCD and MTHFD2 inhibitors for high‐risk acute myeloid leukaemia patients, as suggested by ELN2017‐pathway association
by: Han Sun Kim, et al.
Published: (2023-07-01)

Guerra o negociación: El caso del ELN
by: Ricardo Sánchez Ángel
Published: (2006-07-01)

MULTICENTRE VALIDATION OF A REPRODUCIBLE FLOW CYTOMETRIC SCORE FOR THE DIAGNOSIS OF LOWRISK MYELODYSPLASTIC SYNDROMES: RESULTS OF A EUROPEAN LeukemiaNET STUDY
by: Picone, C, et al.
Published: (2011)

Crystal structure of domain of unknown function 507 (DUF507) reveals a new protein fold
by: Cole E. McKay, et al.
Published: (2023-08-01)

Outcome of 129 Pregnancies in Polycythemia Vera Patients: A Report of the European LeukemiaNET
by: Kai Wille, et al.
Published: (2023-05-01)

P1280: COMPARING TRANSPLANT OUTCOMES OF AML PATIENTS FOR 2017 AND 2022 ELN RISK STRATIFICATION: A REAL-WORLD STUDY FROM A SINGLE CENTER IN CHINA
by: Haixiao Zhang, et al.
Published: (2023-08-01)

AngioCRIME in Acute Myeloid Leukemia (AML)
by: Elizabeth Macintyre, et al.
Published: (2017-12-01)

The Development of Novel Therapies for the Treatment of Acute Myeloid Leukemia (AML)
by: Katherine L. B. Borden, et al.
Published: (2012-11-01)

Nonstationary separation of Nd and Pr by P507 extractant
by: Dorozhko V.A., et al.
Published: (2021-01-01)

Securinine, a myeloid differentiation agent with therapeutic potential for AML.
by: Kalpana Gupta, et al.
Published: (2011-01-01)

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study.
by: Della Porta, MG, et al.
Published: (2012)

Otvoritvena konferenca raziskovalne mreže European Literacy Network (ELN)
by: Špela Arhar Holdt
Published: (2015-12-01)

Elastin (ELN) gene point mutation in patients with inguinal hernia
by: Consuelo Junqueira Rodrigues, et al.
Published: (2006-01-01)

Gobierno y ELN: dos miradas que no se encuentran
by: Alejo Vargas Velásquez
Published: (2004-05-01)

Prognostic analysis according to eln 2017 risk stratification, integrated with patient- and treatment- factors, in a cohort of 608 aml patients : a single center «real life» experience
by: Alessandro Fiorentini
Published: (2020-09-01)

Ferroptosis-related gene signature predicts the clinical outcome in pediatric acute myeloid leukemia patients and refines the 2017 ELN classification system
by: Yu Tao, et al.
Published: (2022-08-01)

Correction Notice: Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party
Published: (2022-03-01)

507 CELLULAR PATHWAYS CONTRIBUTING TO FIBROSIS IN THE BLADDER WALL OF CHILDREN WITH EXSTROPHY
by: B Xie, et al.
Published: (2022-06-01)